Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers

NCT02712411 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Erectile Dysfunction
Prostatic Hyperplasia

Interventions

DRUG: HCP1303
DRUG: HGP1201
DRUG: HIP1402

Sponsor

Hanmi Pharmaceutical Company Limited